Recce Pharmaceuticals Ltd (ASX:RCE)
Australia · Delayed Price · Currency is AUD 0.3250
-0.0150 (-4.41%)
Sep 22, 2026, 3:54 PM AEST
Recce Pharmaceuticals Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -14.96 | -21.43 | -17.66 | -13.08 | -10.99 |
Depreciation & Amortization | 0.36 | 0.36 | 0.37 | 0.22 | 0.19 |
Loss (Gain) From Sale of Investments | 0.53 | - | - | - | - |
Stock-Based Compensation | 1.07 | 1.34 | 0.02 | 0.33 | 0.26 |
Other Operating Activities | -0 | - | - | - | - |
Change in Accounts Receivable | -3.44 | 0.28 | 0.06 | 0.09 | 0.06 |
Change in Accounts Payable | 5.74 | -0.53 | 3.81 | 0.77 | 0.11 |
Change in Other Net Operating Assets | 0.82 | -0.46 | 0.39 | -1.01 | 1.36 |
Operating Cash Flow | -9.89 | -20.44 | -13.01 | -12.69 | -9.01 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -0.06 | -0.03 | -0.14 | -0.04 | -0.04 |
Investment in Securities | -0 | -0.24 | - | - | - |
Other Investing Activities | 0.19 | -0.18 | -0.16 | - | - |
Investing Cash Flow | 0.12 | -0.44 | -0.3 | -0.04 | -0.04 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | - | - | - | 2.88 | - |
Long-Term Debt Issued | 0.06 | 12.22 | 10.09 | - | - |
Total Debt Issued | 0.06 | 12.22 | 10.09 | 2.88 | - |
Long-Term Debt Repaid | -1.71 | -11.92 | -4.51 | -0.17 | -0.14 |
Lease Payments | -0.29 | -0.28 | -0.3 | -0.17 | -0.14 |
Total Debt Repaid | -1.71 | -11.92 | -4.51 | -0.17 | -0.14 |
Net Debt Issued (Repaid) | -1.66 | 0.31 | 5.58 | 2.71 | -0.14 |
Issuance of Common Stock | 3.94 | 28.35 | 11.15 | 0.1 | 0.29 |
Other Financing Activities | -0.27 | -1.74 | -0.56 | -0.1 | -0.39 |
Financing Cash Flow | 2.01 | 26.92 | 16.17 | 2.71 | -0.24 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | 0 |
Net Cash Flow | -7.75 | 6.03 | 2.85 | -10.02 | -9.29 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -9.95 | -20.47 | -13.15 | -12.73 | -9.05 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -105.16% | -272.59% | -261.53% | -291.53% | -293.38% |
Free Cash Flow Per Share | -0.03 | -0.09 | -0.07 | -0.07 | -0.05 |
Levered Free Cash Flow | -1.55 | -12.6 | -7.73 | -8.16 | -4.52 |
Unlevered Free Cash Flow | -0.55 | -11.84 | -7.21 | -8.05 | -4.51 |
Free Cash Flow After Leases | -10.24 | -20.75 | -13.45 | -12.9 | -9.19 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Income Tax Paid | -5.31 | -6.74 | -4.91 | -4.31 | -3.08 |
Change in Working Capital | 3.12 | -0.71 | 4.27 | -0.15 | 1.53 |